Effects of antipsychotic treatment on psychopathology and motor symptoms. A placebo-controlled study in healthy volunteers

被引：0
作者：
Tanja Veselinović
Holger Schorn
Ingo Vernaleken
Katharina Schiffl
Christoph Hiemke
Gerald Zernig
Ruben Gur
Gerhard Gründer
机构：
[1] RWTH Aachen University,Department of Psychiatry, Psychotherapy and Psychosomatics
[2] JARA—Translational Brain Medicine,Neuropsychiatry Division, Department of Psychiatry
[3] University of Pennsylvania and the Philadelphia Veterans Administration Medical Center,Institute of Medical Statistics
[4] RWTH Aachen University,Department of Psychiatry and Psychotherapy
[5] University Medical Centre Mainz,Experimental Psychiatry Unit, Department of Psychiatry and Psychotherapy
[6] Medical University Innsbruck,undefined
来源：
Psychopharmacology | 2011年 / 218卷
关键词：
Dopamine; Antipsychotics; Psychopathology; Healthy volunteers; Aripiprazole; Reserpine; Haloperidol;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：733 / 748
页数：15
相关论文
共 50 条
  • [41] Safety and Tolerability of Lersivirine, a Nonnucleoside Reverse Transcriptase Inhibitor, During a 28-Day, Randomized, Placebo-Controlled, Phase I Clinical Study in Healthy Male Volunteers
    Davis, John
    Hackman, Frances
    Ndongo, Marie-Noella
    Choo, HengWee
    Lewis, Drew
    Tawadrous, Margaret
    Goodrich, James
    Langdon, Grant
    CLINICAL THERAPEUTICS, 2010, 32 (11) : 1889 - 1895
  • [42] A double-blind study in healthy volunteers to assess the effects on sleep of pregabalin compared with alprazolam and placebo
    Hindmarch, I
    Dawson, J
    Stanley, N
    SLEEP, 2005, 28 (02): : 187 - 193
  • [43] Effects of Amantadine on Tardive Dyskinesia: A Randomized, Double-Blind, Placebo-Controlled Study
    Pappa, Sofia
    Tsouli, Sofia
    Apostolou, George
    Mavreas, Venetsanos
    Konitsiotis, Spiridon
    CLINICAL NEUROPHARMACOLOGY, 2010, 33 (06) : 271 - 275
  • [44] Treatment of restless legs syndrome with pregabalin A double-blind, placebo-controlled study
    Garcia-Borreguero, D.
    Larrosa, O.
    Williams, A. -M.
    Albares, J.
    Pascual, M.
    Palacios, J. C.
    Fernandez, C.
    NEUROLOGY, 2010, 74 (23) : 1897 - 1904
  • [45] Modafinil improves antipsychotic-induced parkinsonism but not excessive daytime sleepiness, psychiatric symptoms or cognition in schizophrenia and schizoaffective disorder: A randomized, double-blind, placebo-controlled study
    Lohr, James B.
    Liu, Lianqi
    Caligiuri, Michael P.
    Kash, Taylor P.
    May, Todd A.
    Murphy, Jody DelaPena
    Ancoli-Israel, Sonia
    SCHIZOPHRENIA RESEARCH, 2013, 150 (01) : 289 - 296
  • [46] The Effects of Quetiapine on Craving and Withdrawal Symptoms in Methamphetamine Abuse: A Randomized, Double-Blind, Placebo-Controlled Trial
    Javdan, Najme Sadat
    Ghaderi, Amir
    Banafshe, Hamid Reza
    INTERNATIONAL JOURNAL OF MEDICAL TOXICOLOGY AND FORENSIC MEDICINE, 2020, 10 (04):
  • [47] Reducing antipsychotic-induced weight gain in schizophrenia: a double-blind placebo-controlled study of reboxetine–betahistine combination
    Michael Poyurovsky
    Camil Fuchs
    Artashez Pashinian
    Adva Levi
    Ronit Weizman
    Abraham Weizman
    Psychopharmacology, 2013, 226 : 615 - 622
  • [48] The effects of intranasal esketamine (84 mg) and oral mirtazapine (30 mg) on on-road driving performance: a double-blind, placebo-controlled study
    van de Loo, Aurora J. A. E.
    Bervoets, Adriana C.
    Mooren, Loes
    Bouwmeester, Noor H.
    Garssen, Johan
    Zuiker, Rob
    van Amerongen, Guido
    van Gerven, Joop
    Singh, Jaskaran
    Van der Ark, Peter
    Fedgchin, Maggie
    Morrison, Randall
    Wajs, Ewa
    Verster, Joris C.
    PSYCHOPHARMACOLOGY, 2017, 234 (21) : 3175 - 3183
  • [49] GENERAL WELL-BEING DURING TREATMENT WITH DIFFERENT ACE-INHIBITORS - 2 DOUBLE-BLIND PLACEBO-CONTROLLED CROSS-OVER STUDIES IN HEALTHY-VOLUNTEERS
    DAHLOF, C
    DIMENAS, E
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1992, 43 (04) : 375 - 379
  • [50] Sildenafil adjunctive therapy to risperidone in the treatment of the negative symptoms of schizophrenia: a double-blind randomized placebo-controlled trial
    Akhondzadeh, Shahin
    Ghayyoumi, Raofeh
    Rezaei, Farzin
    Salehi, Bahman
    Modabbernia, Amir-Hossein
    Maroufi, Azad
    Esfandiari, Gholam-Reza
    Naderi, Mehrangiz
    Ghebleh, Fariba
    Tabrizi, Mina
    Rezazadeh, Shams-Ali
    PSYCHOPHARMACOLOGY, 2011, 213 (04) : 809 - 815
12345